GO
Loading...

Drug Retail

More

  • Pot start-ups pitch to angel investors     Monday, 23 Jun 2014 | 2:41 PM ET

    Paid members of the Arcview Group have committed to investing at least $50,000 into the budding cannabis industry. Members are in Denver hearing pitches from pot start-ups, reports CNBC's Josh Lipton.

  • June 19- Drugstore operator Rite Aid Corp said higher drug costs and a fall in reimbursement rates would continue into the second quarter, sending it shares down 4.4 percent. Rite Aid's shares have been on a tear for most of the past year, until the company warned on first-quarter profit and cut its full-year earnings forecast earlier this month.

  • June 19- Drugstore operator Rite Aid Corp's quarterly profit more than halved, hurt by higher-than-expected drug costs and a bigger-than-anticipated fall in reimbursement rates. Rite Aid said a delay in the expected fall in prices of generic medicines raised its drug costs.

  • The nation's largest drugstore chain, based in Illinois, is under pressure from some of its shareholders to do a deal known as a tax inversion with Alliance Boots Holdings Ltd that would shift Walgreen's tax domicile overseas.

  • June 5- Drug retailer Rite Aid Corp estimated first-quarter profit much below analysts' expectations due to higher-than-expected drug costs and a bigger-than-expected fall in reimbursement rates. Rite Aid's shares fell as much as 14 percent on Thursday on the New York Stock Exchange.

  • Incyte CEO: Science will drive success     Monday, 2 Jun 2014 | 2:52 PM ET

    Incyte CEO Herve Hoppenot, provides insight to his company's progress on cancer research at this year's ASCO conference.

  • Ariad CEO talks Iclusig trials     Monday, 2 Jun 2014 | 12:34 PM ET

    Ariad Pharmaceuticals CEO Dr. Harvey Berger, says investors are responding to his company's better overall picture, and the progress on its leukemia drug Iclusig.

  • ASCO cancer care conference kicks off     Friday, 30 May 2014 | 1:01 PM ET

    In the U.S., half of all men and a third of all women will develop cancer in their lifetimes. CNBC's Meg Tirrell reports which stocks analysts are eyeing into the conference.

  • Costco results miss estimates as costs rise Thursday, 29 May 2014 | 5:24 AM ET
    A Costco store in Alhambra, Calif.

    Costco reported third-quarter results below analysts' estimates hurt by an increase in merchandise costs and other expenses.

  • Over-the-counter Cialis?     Wednesday, 28 May 2014 | 2:16 PM ET

    CNBC's Meg Tirrell reports Sanofi and Eli Lilly announced an agreement to pursue regulatory approval of an over-the-counter version of erectile dysfunction drug Cialis.

  • Zeroing in on rising drug prices     Friday, 23 May 2014 | 4:32 PM ET

    CNBC's Meg Tirrell reports on the high cost of drug prices. Ezekial Emanuel, University of Pennsylvania; and Alex Brill, American Enterprise Institute, share their concerns and solutions for the issue.

  • Big move for PTC Therapeutics     Friday, 23 May 2014 | 2:40 PM ET

    PTC Therapeutics skyrockets on a recommendation for approval in Europe for its Duchenne Muscular Dystrophy drug. CNBC's Meg Tirrell provides insight to the disease and treatment options. Shane Kovacs, PTC Therapeutics CFO, looks at the move in the stock.

  • Drug pricing in US versus world     Friday, 23 May 2014 | 1:49 PM ET

    CNBC's Meg Tirrell reports why drugs in the U.S. versus the rest of the world are priced differently.

  • UPDATE 3-Staples warns of falling sales, shares slump Tuesday, 20 May 2014 | 1:48 PM ET

    May 20- Staples Inc forecast a fall in sales in the current quarter as customers shift to e-retailers, mass merchants and drugstores to buy their office supplies, and the company reported its weakest quarterly gross margins since May 2003.

  • UPDATE 1-Staples forecasts fall in sales, shares drop Tuesday, 20 May 2014 | 7:14 AM ET

    May 20- Staples Inc forecast a decline in sales in the current quarter as it struggles to win back shoppers who have shifted office supply purchases to e-retailers, mass merchants and drugstores.

  • Ethics of 'right to try' laws     Tuesday, 6 May 2014 | 2:35 PM ET

    Lawmakers in four states are considering changing the rules to allow terminally ill people access to experimental drugs before they have FDA approval. Kenneth Goodman, University of Miami, thinks this would be a bad bet for patients. Miles Nadal, MDC Partners Chairman & CEO, weighs in.

  • Pharma deal of the day     Tuesday, 6 May 2014 | 12:27 PM ET

    CNBC's Meg Tirrell spoke with Merck Chairman & CEO Ken Frazier about the company's decision to sell its over the counter health care products to Bayer.

  • *Apple shares in spotlight after closing above $600. *Shares of Office Depot Inc jumped 10 percent in premarket trading even as it reported a quarterly loss and said it would shut at least 400 stores in the United States, hurt by competition from e-retailers, mass market chains and drugstores.

  • *Apple shares in spotlight after closing above $600. *Shares of Office Depot Inc jumped 8 percent in premarket trading even as it reported a quarterly loss and said it would shut at least 400 stores in the United States, hurt by competition from e-retailers, mass market chains and drugstores.

  • Office Depot to close 400 U.S. stores, posts loss Tuesday, 6 May 2014 | 7:13 AM ET

    May 6- Office Depot Inc said it would close at least 400 stores in the United States as shoppers shift their office supply purchases to e-retailers, mass market chains and drugstores. Office Depot, which also reported a quarterly net loss, said it expects to close 150 stores this year.